abstract |
The present invention relates to pyrrolidine derivatives of the formula (I), n nor a physiologically tolerated salt thereof.n n The invention relates to pharmaceutical compositions comprising such pyrrolidine derivatives, and the use of such pyrrolidine derivatives for therapeutic purposes. The pyrrolidine derivatives are GlyT1 inhibitors. |